Scancell has a pipeline of five anti-glycan antibodies, with SC129 accompanied by fucosyl GM1-targeting SC134 for small cell ...

The Association of British Pharmaceutical Industry (ABPI) warns in the document that lack of resources, and the knock-on ...

In June, CSL Seqirus received an order for 665,000 pre-pandemic bird flu vaccines from the European Commission that will be ...

Applied Therapeutics has been sent a warning letter from the FDA over a clinical trial of its rare disease therapy govorestat ...

To discuss the importance of outcome measures further, pharmaphorum spoke with Sonia Bothorel, Managing Director of Mapi ...

Learn more about the summit in the Event Guide here.

Join us at the 2nd Peptide-Based Therapeutics Summit, where we’ll unite the leading minds in peptide science to explore the ...

Cytokinetics should hear back from the FDA next September about its marketing application for aficamten, which is vying to ...

Kelun-Biotech has become the second drugmaker to bring a TROP2-directed antibody-drug conjugate to regulatory approval, ...

New guidance from health technology assessment (HTA) agency NICE backs the use of Wainzua (eplontersen) to treat stage 1 or 2 ...

The deal with Tubulis gives Gilead access to the German biotech's ADC technology platform, designed to make ADCs more stable, ...

Since the start of the year, Ipsen has bolstered its oncology pipeline with two ADC alliances – with Foreseen Bio and Sutro ...